Seizinger Bernd R.

CIK 00017890423 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001789042

Recent Transactions

25 trades

Purchase
ONCOLYTICS BIOTECH INC$ONCY
Common Shares
2026-01-16$1.04/sh+100,000→ 466,991 total
Award
Aprea Therapeutics, Inc.$APRE
Stock Options (Right to Buy)
2025-06-05+4,185→ 4,185 total
Award
Aprea Therapeutics, Inc.$APRE
Common Stock
2025-06-05+1,045→ 45,775 total
Purchase
Aprea Therapeutics, Inc.$APRE
Common Stock
2024-10-11$2.68/sh+10,000→ 44,730 total
Award
Aprea Therapeutics, Inc.$APRE
Stock Options (Right to Buy)
2024-06-20+4,185→ 4,185 total
Award
Aprea Therapeutics, Inc.$APRE
Common Stock
2024-06-20+1,045→ 34,730 total
Purchase
Aprea Therapeutics, Inc.$APRE
Common Stock
2024-03-13$7.29/sh+6,860→ 33,685 total
Purchase
Aprea Therapeutics, Inc.$APRE
Tranche A Warrant
2024-03-13+3,430→ 3,430 total
Purchase
Aprea Therapeutics, Inc.$APRE
Tranche B Warrant
2024-03-13+3,430→ 3,430 total
Award
Aptose Biosciences Inc.$APTOF
Director Stock Option (Right to Buy)
2024-02-05+3,333→ 3,333 total
Purchase
Aptose Biosciences Inc.$APTOF
Common Shares
2023-09-22$3.14/sh+17,000→ 17,000 total
Award
Aprea Therapeutics, Inc.$APRE
Common Stock
2023-08-23+500→ 26,825 total
Award
Aprea Therapeutics, Inc.$APRE
Stock Options (Right to Buy)
2023-08-23+2,000→ 2,000 total
Purchase
Aprea Therapeutics, Inc.$APRE
Common Stock
2023-06-07$3.68/sh+6,029→ 26,325 total
Purchase
Aprea Therapeutics, Inc.$APRE
Common Stock
2023-06-06$3.63/sh+4,068→ 20,296 total
Award
Aptose Biosciences Inc.$APTOF
Stock Option (right to buy)
2023-01-19+100,000→ 100,000 total
Award
Aptose Biosciences Inc.$APTOF
Stock Option (right to buy)
2022-09-14+50,000→ 50,000 total
Award
Aprea Therapeutics, Inc.$APRE
Stock Option (right to Buy)
2022-07-28+29,575→ 29,575 total
Award
Aprea Therapeutics, Inc.$APRE
Common Stock
2022-07-28+5,995→ 324,575 total
Purchase
Aprea Therapeutics, Inc.$APRE
Common Stock
2022-05-18$0.71/sh+50,000→ 318,580 total
Award
Aprea Therapeutics, Inc.$APRE
Common Stock
2021-06-30+4,610→ 268,580 total
Award
Aprea Therapeutics, Inc.$APRE
Stock Option (Right to Buy)
2021-06-30+22,750→ 22,750 total
Award
Aprea Therapeutics, Inc.$APRE
Stock Option (right to Buy)
2020-06-30+5,600→ 5,600 total
Exercise/Conversion
Aprea Therapeutics, Inc.$APRE
Stock Option (right to buy)
2019-10-07−263,970→ 0 total
Exercise/Conversion
Aprea Therapeutics, Inc.$APRE
Common Stock
2019-10-07$0.07/sh+263,970→ 263,970 total

Companies

Recent Filings

Address

C/O ONCOLYTICS BIOTECH INC. 4350 EXECUTIVE DRIVE, SUITE 325

SAN DIEGO, CA, 92121

View on SEC.gov